DecisionMap Wealth Management’s Eli Lilly LLY Stock Holding History

DecisionMap Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	942 -118	-11%	-$121K	0.63%	37
2026 Q1	$975K	Sell	1,060 -91	-8%	-$92.3K	0.63%	41
2025 Q4	$1.24M	Sell	1,151 -122	-10%	-$117K	0.76%	34
2025 Q3	$971K	Buy	1,273 +9	+0.7%	+$6.7K	0.62%	41
2025 Q2	$985K	Buy	1,264 +666	+111%	+$518K	0.68%	38
2025 Q1	$494K	Buy	598 +36	+6%	+$30K	0.38%	73
2024 Q4	$434K	Buy	+562	New	+$465K	0.34%	75

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

DecisionMap Wealth Management's LLY Position: Q2 2026 in Review

DecisionMap Wealth Management reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $121K and leaving 942 shares worth $1.13M. The position accounts for 0.63% of the portfolio, ranked #37.

DecisionMap Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.24M in Q4 2025. 1,085 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

DecisionMap Wealth Management held 942 shares of Eli Lilly worth $1.13M as of Q2 2026.
DecisionMap Wealth Management sold 118 Eli Lilly shares in Q2 2026, an estimated $121K.
Eli Lilly made up 0.63% of DecisionMap Wealth Management's portfolio in Q2 2026, its #37 holding.
DecisionMap Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
DecisionMap Wealth Management's Eli Lilly position peaked at $1.24M in Q4 2025.
1,085 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DecisionMap Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.